SUPRIYABSESupriya Lifescience LtdMediumNeutral
Announced Sat, 23 May · 16:24 IST

Results Earnings Call for the Audited Financial Results for quarter and year ended march 31, 2026 is enclosed herewith along with dial in details and link for joining the call. Kindly ....

Investor Communications View source PDF

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹773.00
prior close
₹775.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.6+0.4+1.3+0.9+4.9+25.3+35.8+18.2+23.4+21.9+21.5+9.4
Up moveDown movePending
AI summary

Supriya Lifescience Ltd has announced an earnings call scheduled for Thursday, May 28, 2026 at 11:00 AM IST to discuss the company's operational and financial performance for Q4 FY26 and the full year ended March 31, 2026. The call will feature key management including Executive Chairman Dr. Satish Wagh, Managing Director Dr. Saloni Wagh, and CFO Mr. Krishna Raghunathan. The investor presentation will be shared separately with the exchanges. EY IR contacts are also listed for the call. The announcement is made pursuant to SEBI Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Likely market impact

This is a standard procedural announcement informing investors of an upcoming earnings call; no new financial data or strategic guidance is provided in this filing. The actual impact on the stock will depend on what is disclosed during the call.